In contrast, CLL patients had low frequencies of CD4+ naïve T cells compared to healthy donors, which significantly increased after long-term zanubrutinib treatment (Additional file 1: Figure S4A–D). Here, CD4 is linked to B-cell chronic lymphocytic leukemia.